ResMed head passes mantle to son
This article was originally published in Clinica
Respiratory disorder therapy firm ResMed's founder, chairman and CEO Dr Peter Farrell is passing the role of chief executive over to his son Michael Farrell, who is currently head of the firm's Americas operations. Mr Farrell Jnr has been at ResMed since 2000 and has held a number of senior sales and business development roles. Robert Douglas, the current chief operating officer, will assume the additional responsibility of president. Dr Farrell will remain executive chairman and work with his son and Mr Douglas on an as-needed basis through the end of 2013, after which he will become non-executive chairman. Mr Farrell's existing role of president, Americas, will be taken up by ResMed's current chief strategy officer and president of ventures and initiatives strategic unit, Dr Jim Hollingshead.